Design a personal diabetes assistant
Medtronic worked with IBM iX® and IBM Watson Health® teams to develop the Sugar.IQ personal diabetes assistant, an intelligent app powered by IBM Watson® cognitive computing technology. Sugar.IQ is designed to make daily diabetes management smarter and more personalized than ever before. The app continually analyzes how an individual’s glucose levels respond to food, insulin intake, daily routines and other factors. By uncovering patterns and real-time, eye-opening insights, people can understand their glucose in context to their lifestyle choices.
Using the IBM Design Thinking framework and principles, the iX team partnered with Medtronic to develop the app’s user interface and user experience, and assisted in delivering an end-to-end solution. Features include a smart food logging system, motivational insights, a glycemic assistant, a data tracker and glycemic insights, Glycemic Assist event tracking, and personalized diabetes insights. The team also strategized ways to incorporate cognitive capabilities into the app and researched a way to differentiate this app from other diabetes apps in the market today.
The Sugar.IQ personal diabetes assistant is exclusively available to Guardian Connect continuous glucose monitoring (CGM) customers on insulin injections and is available for iOS-based mobile devices in the US.